We thank all study participants for participating in the clinical trial, the Karolinska Trial Alliance staff and research nurses for organizing the recruitment and scheduling of study participants, vaccination, and clinical sampling. Additionally, we thank J. Verner-Carlsson and staff scientists at the Swedish Public Health Agency for support with neutralization assays and BSL-3 instruction. Further thanks to W. Christ for support in the BSL-3 facility, P. Jahnmatz for discussions around the FluoroSpot reader assessment, and D. Wullimann for discussions and advice on the project.